Skip to Main Content
☰ ATSU Navigation

ATSU Kirksville Institutional Review Board: Expedited Reviews

Expedited Reviews

See MO Full IRB Manual for more information: 

Which research studies qualify for an expedited review? 

How is an expedited review different from an exempt review? 

  • Projects not eligible for an exempt review may be eligible for an expedited review.
  • Expedited does not mean that the review is less rigorous or happens more quickly than convened review.
  • Types of research considered to involve minimal risk.
  • Research may qualify for expedited review if it is judged to involve only minimal risk, does not include intentional deception, and includes appropriate informed consent procedures.
  • Common protocols reviewed and approved as expedited include the following:
    • Studies involving the collection of identifiable information in surveys, interviews, or focus groups, and sensitive information that is also identifiable. • Study involving the analysis of voice recordings.
    • Study of blood samples from healthy volunteers, depending on volume of blood drawn.
    • Study involving collection of hair or saliva samples.  • Retrospective and Prospective Chart Reviews.  
    • Please note: prospective research requires informed consent.  The full list of categories of research that may be reviewed as expedited can be found in 45 CFR 46.110. 

HHS Human Subject Research Decision Charts

Not sure which type of review application is right for your research? 

Use the HHS Human Subject Decision Charts

The graphic charts are intended to aid those who need to decide if an activity is research involving human subjects that must be reviewed by an institutional review board (IRB) and whether informed consent or the documentation of informed consent can be waived under the 2018 Requirements found for the U.S. Department of Health and Human Services (HHS) at 45 CFR part 46, Subpart A.

Additional Forms

Other forms you may use during the course of your non-Exempt Minimal Risk research, include:

  • The Continuing Review Report will be sent to the Investigator before the continuing report is due in the IRB office.

  • The Final Report form will NOT be sent to Investigators.  Investigators should submit the final report to the IRB within 30 days of completion of the study.

  • The Amendment Request form should be completed when there are amendments to the protocol, consent forms or participant communication documents, such as advertisements, flyers or brochures.  Informational letters to referral sources, such as physicians or other health professionals do not require IRB review and approval.

  • The Serious Adverse Event form should be submitted to the IRB within 10 working days of Investigator notification of participant injury or serious illness.  In the event of the death of a study participant, for any reason, the IRB should be notified within 24 hours of discovery.

  • The Unanticipated Problems form should be completed when unforeseen incidents occur that could impact participant safety or data integrity.  Issues ranging from deviations in the consent process, to protocol violations or a breach of participant confidentiality should be reported on this form.  The Unanticipated Problems Form should be submitted to the IRB within 10 working days of discovery.